Free Trial

Processa Pharmaceuticals (PCSA) Insider Trading & Ownership

Processa Pharmaceuticals logo
$0.91 +0.01 (+1.11%)
(As of 11/20/2024 ET)

Processa Pharmaceuticals (NASDAQ:PCSA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.00%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$105,895.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get PCSA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Processa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PCSA Insider Buying and Selling by Quarter

Processa Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/7/2024David YoungInsiderBuy21,000$2.45$51,450.00  
1/31/2024Patrick LinInsiderBuy2,500$2.37$5,925.00  
1/30/2024George K NgCEOBuy10,000$2.70$27,000.00  
1/30/2024Justin W YorkeDirectorBuy8,000$2.69$21,520.00  
(Data available from 1/1/2013 forward)

PCSA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Processa Pharmaceuticals includes David Young, George K Ng, Justin W Yorke, and Patrick Lin. Learn more on insiders at PCSA.

13.00% of Processa Pharmaceuticals stock is owned by insiders. Learn more on PCSA's insider holdings.

The following insiders have purchased PCSA shares in the last 24 months: David Young ($103,450.00), George K Ng ($27,000.00), Justin W Yorke ($21,520.00), and Patrick Lin ($5,925.00).

Insiders have purchased a total of 45,500 PCSA shares in the last 24 months for a total of $157,895.00 bought.

Processa Pharmaceuticals Key Executives



This page (NASDAQ:PCSA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners